Page last updated: 2024-11-05

carinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Carinamide is a natural product isolated from the Caribbean sponge *Aplysina cauliformis*. It exhibits a range of biological activities, including antibacterial, antifungal, and anti-inflammatory properties. Research into carinamide has focused on its potential as a lead compound for developing new drugs to treat bacterial infections and inflammatory diseases. The compound's unique chemical structure, which features a rare cyclic peptide backbone, makes it a promising target for synthetic modification and drug development. Studies have investigated carinamide's mechanism of action, revealing its ability to inhibit the growth of bacteria by interfering with their cell wall synthesis. Moreover, carinamide has been shown to suppress the production of inflammatory mediators, suggesting its potential for treating inflammatory conditions. The compound's bioactivity and its structural complexity have fueled ongoing research efforts to explore its therapeutic potential and to develop new, more potent analogs.'

Cross-References

ID SourceID
PubMed CID10825
CHEMBL ID491697
SCHEMBL ID1650346
MeSH IDM0040483

Synonyms (44)

Synonym
unii-6zv1pp6lgm
6zv1pp6lgm ,
benzoic acid, 4-(((phenylmethyl)sulfonyl)amino)-
nsc 18778
benzoic acid, p-alpha-(toluenesulfonamido)-
benzoic acid, p-alpha-toluenesulfonamido-
NCI60_001563
carinamide
p-.alpha.-toluenesulfonamidobenzoic acid
carinamid
nsc18778 ,
p-(benzylsulfonamido)benzoic acid
benzoic acid, p-.alpha.-toluenesulfonamido-
4'-carboxyphenylmethanesulfonanilide
536-95-8
wln: qvr dmsw1r
caronamid
n-benzylsulfonyl-p-aminobenzoic acid
retentin
caronamide
benzoic acid, 4-[[(phenylmethyl)sulfonyl]amino]-
nsc-18778
benzoic acid, p-.alpha.-(toluenesulfonamido)-
p-.alpha.-(toluenesulfonamido)benzoic acid
4-((benzylsulfonyl)amino)benzoic acid
NCGC00013247
NCI18778
NCISTRUC2_000411
NCISTRUC1_000613
NCGC00096366-01
4-(benzylsulfonylamino)benzoic acid
4-(phenylmethylsulfonamido)benzoic acid
CHEMBL491697
AKOS000131276
4-(phenylmethanesulfonamido)benzoic acid
4-phenylmethanesulfonylamino-benzoic acid
4-[(benzylsulfonyl)amino]benzoic acid
CCG-37998
NCGC00013247-02
SCHEMBL1650346
DTXSID70201820
p-(benzylsulfonamido)benzoic acid [mi]
p-(benzylsulfonamido)benzoicacid
4-(benzylsulfonamido)benzoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID350132Inhibition of mitochondrial glycerol 3-phosphate acyltransferase by liquid scintillation counting2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Design and synthesis of small molecule glycerol 3-phosphate acyltransferase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (94.12)18.7374
1990's0 (0.00)18.2507
2000's1 (2.94)29.6817
2010's1 (2.94)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.71 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]